RNA as a drug target: chemical, modelling, and evolutionary tools
- 11 February 1998
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 9 (1) , 66-73
- https://doi.org/10.1016/s0958-1669(98)80086-4
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- A Structural Basis for RNA−Ligand InteractionsChemical Reviews, 1997
- RNA as a drug targetChemistry & Biology, 1997
- Strategy for RNA recognition by yeast histidyl-tRNA synthetaseBioorganic & Medicinal Chemistry, 1997
- An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replicationProceedings of the National Academy of Sciences, 1997
- Combinatorial thinking in chemistry and biologyProceedings of the National Academy of Sciences, 1997
- In vitro selection of aptamers: the dearth of pure reasonCurrent Opinion in Structural Biology, 1996
- A convergent solid-phase synthesis of actinomycin analogues—towards implementation of double-combinatorial chemistryBioorganic & Medicinal Chemistry, 1996
- Design and analysis of RNA structure-specific agents as potential antiviralsJournal of Molecular Recognition, 1996
- Rapid Combinatorial Synthesis of Aminoglycoside Antibiotic Mimetics: Use of a Polyethylene Glycol-Linked Amine and a Neamine-Derived Aldehyde in Multiple Component Condensation as a Strategy for the Discovery of New Inhibitors of the HIV RNA Rev Responsive ElementJournal of the American Chemical Society, 1996
- Using in vitro nucleic acid selections for conventional drug designDrug Development Research, 1994